Leite John

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1

Veracyte, Inc.

Drugs » Biotechnology

Chief Commercial Officer-CLIA:

Holdings: 76.17K shares

Sentiment

Insider Trading Sentiment: Sell

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

($163.16K) Net Amount
Buy:0--
Sell:($163.16K)$29.78